pfizer | Al Majalla

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15, Jan 2023

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022. REUTERS/Brian Snyder/Illustration

U.S. Government to Test Pfizer's Paxlovid For Long COVID

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID,…

27, Oct 2022

Pfizer To Supply Up To 6 mln COVID Pill Courses For Lower Income Countries

Pfizer Inc (PFE.N) said it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seek to address worldwide disparities…

23, Sep 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25, Jul 2021

Popular
Editor's Pick

Politics

Frederic Hof: Israel-Syria peace is far off, but a truce is crucial

28 May 2025

The former US envoy to Damascus tells Al Majalla how to find a path to a lasting settlement and a new place in the Middle East, from his unique perspective and first-hand experience in Assad-era talks

Johaina Khaldieh

Opinion

The Israel-Houthi war achieves nothing and hurts both sides

28 May 2025

Killing Yemeni civilians further ruins Israel's global image. Meanwhile, the Houthis cannot defeat Israel militarily.

Anwar Al-Ansi

Sara Padovan

Business & Economy

The history of tariffs is still being written

29 May 2025

A US federal court has blocked Trump's tariffs and ruled that the president doesn't have unilateral authority to impose them, dealing a major blow to his economic policy

Toufic Chanbour

Culture & Social Affairs

Palestinian poet Mosab Abu Toha: Pulitzer Prize is a recognition of our story

26 May 2025

The US-based writer does not hold back in what he pens for American readers, nor is he censored. There is just one word that he is forbidden from using.

Houssam Marouf

Sara Padovan

Business & Economy

It’s time to build a regional climate fund

27 May 2025

As global climate finance falters and US support disappears, the MENA region faces a widening funding gap. Now is the time to create a regional climate finance mechanism.

Léa Eid

Sections

Regions

More

LATEST ISSUE

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

U.S. Government to Test Pfizer's Paxlovid For Long COVID

Pfizer To Supply Up To 6 mln COVID Pill Courses For Lower Income Countries

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

Frederic Hof: Israel-Syria peace is far off, but a truce is crucial

The Israel-Houthi war achieves nothing and hurts both sides

The history of tariffs is still being written

Palestinian poet Mosab Abu Toha: Pulitzer Prize is a recognition of our story

It’s time to build a regional climate fund

OPINIONS

‘Children fighting in a park’ with drones and long-range bombers

US–China trade truce is a pause for breath in a new Cold War

‘You may leave’: a 1936 meeting between Syrian and Zionist leaders

The Orientalists who entered Mecca in disguise

Sign up for the Weekly Newsletter